All lobbying filings

RIDGELINE ADVOCACY GROUP LLC

RIDGELINE ADVOCACY GROUP LLC filed a Q2 report for ARKEMA INC. on July 21, 2025, reporting $60,000 in lobbying income.

Lobbying for ARKEMA INC. · A specialty chemicals and advanced materials company

All filings by RIDGELINE ADVOCACY GROUP LLC · Everything ARKEMA INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$60,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 1

KYLE CORMNEY

Previously held: Policy Advisor, Tom Price; LD, Tom Price; Senior Policy Advisor, House Budget Committee.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Taxation/Internal Revenue Code

Advisory and advocacy services focused on chemical management, environmental issues, and manufacturing and related issues, including tax issues. One Big Beautiful Bill (H.R.1)

Manufacturing

Advisory and advocacy services focused on environmental issues, and manufacturing and related issues, including tax issues.

Chemicals/Chemical Industry

Advisory and advocacy services focused on chemical management, environmental issues, and manufacturing and related issues, including tax issues. One Big Beautiful Bill (H.R.1).

Environment/Superfund

Advisory and advocacy services focused on chemical management, environmental issues, and manufacturing and related issues, including tax issues.

Bills named in this filing 1

H.R. 1
One Big Beautiful Bill Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.